Literature DB >> 17410332

Antizyme and antizyme inhibitor activities influence cellular responses to polyamine analogs.

J L A Mitchell1, T K Thane, J M Sequeira, L J Marton, R Thokala.   

Abstract

Close structural analogs of spermidine and spermine, polyamine mimetics, are potential chemotheraputic agents as they depress cellular polyamines required for tumor growth. Specific mimetic analogs stimulate synthesis of the regulatory protein antizyme (AZ), which not only inactivates the initial enzyme in polyamine biosynthesis but also inhibits cellular uptake of polyamines. The role of AZ induction in influencing cellular uptake of representative analogs was investigated using three analogs produced by Cellgate Inc., CGC-11047, CGC-11102, and CGC-11144, which exhibit markedly distinct AZ-inducing potential. An inverse correlation was noted between the AZ-inducing activity of a compound and the steady-state levels accumulated in cells. As some tumor cells over express AZI as a means of enhancing the polyamines required for aggressive growth, analog sensitivity was examined in transgenic CHO cells expressing exogenous antizyme inhibitor protein (AZI). Although AZI over expression increased cell sensitivity to analogs, the degree of this affect varied with the analog used.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17410332     DOI: 10.1007/s00726-007-0523-2

Source DB:  PubMed          Journal:  Amino Acids        ISSN: 0939-4451            Impact factor:   3.520


  14 in total

1.  Knockdown of ornithine decarboxylase antizyme 1 causes loss of uptake regulation leading to increased N1, N11-bis(ethyl)norspermine (BENSpm) accumulation and toxicity in NCI H157 lung cancer cells.

Authors:  Alison V Fraser; Andrew C Goodwin; Amy Hacker-Prietz; Elizabeth Sugar; Patrick M Woster; Robert A Casero
Journal:  Amino Acids       Date:  2011-08-04       Impact factor: 3.520

2.  A phase I dose-escalation study of the polyamine analog PG-11047 in patients with advanced solid tumors.

Authors:  Tracy Murray Stewart; Apurva A Desai; Michael L Fitzgerald; Laurence J Marton; Robert A Casero
Journal:  Cancer Chemother Pharmacol       Date:  2020-05-23       Impact factor: 3.333

Review 3.  Evidence of a role for antizyme and antizyme inhibitor as regulators of human cancer.

Authors:  Rachelle R Olsen; Bruce R Zetter
Journal:  Mol Cancer Res       Date:  2011-08-17       Impact factor: 5.852

Review 4.  Antizyme and antizyme inhibitor, a regulatory tango.

Authors:  Chaim Kahana
Journal:  Cell Mol Life Sci       Date:  2009-04-28       Impact factor: 9.261

5.  Gene expression analysis of HCT116 colon tumor-derived cells treated with the polyamine analog PG-11047.

Authors:  Natalia A Ignatenko; Hagit F Yerushalmi; Ritu Pandey; Karen L Kachel; David E Stringer; Laurence J Marton; Eugene W Gerner
Journal:  Cancer Genomics Proteomics       Date:  2009 May-Jun       Impact factor: 4.069

6.  ATP13A3 and caveolin-1 as potential biomarkers for difluoromethylornithine-based therapies in pancreatic cancers.

Authors:  Meenu Madan; Arjun Patel; Kristen Skruber; Dirk Geerts; Deborah A Altomare; Otto Phanstiel Iv
Journal:  Am J Cancer Res       Date:  2016-06-01       Impact factor: 6.166

7.  In vitro and in vivo effects of the conformationally restricted polyamine analogue CGC-11047 on small cell and non-small cell lung cancer cells.

Authors:  Amy Hacker; Laurence J Marton; Michelle Sobolewski; Robert A Casero
Journal:  Cancer Chemother Pharmacol       Date:  2008-02-27       Impact factor: 3.333

8.  Spermidine, a sensor for antizyme 1 expression regulates intracellular polyamine homeostasis.

Authors:  Ramesh M Ray; Sujoy Bhattacharya; Mitul N Bavaria; Mary Jane Viar; Leonard R Johnson
Journal:  Amino Acids       Date:  2014-05-14       Impact factor: 3.520

9.  Histone deacetylase inhibition overcomes drug resistance through a miRNA-dependent mechanism.

Authors:  Tracy Murray-Stewart; Christin L Hanigan; Patrick M Woster; Laurence J Marton; Robert A Casero
Journal:  Mol Cancer Ther       Date:  2013-08-13       Impact factor: 6.261

10.  Oligoamine analogues in combination with 2-difluoromethylornithine synergistically induce re-expression of aberrantly silenced tumour-suppressor genes.

Authors:  Yu Wu; Nora Steinbergs; Tracy Murray-Stewart; Laurence J Marton; Robert A Casero
Journal:  Biochem J       Date:  2012-03-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.